Tennessee Valley Asset Management Partners Armata Pharmaceuticals, Inc. Transaction History

Tennessee Valley Asset Management Partners

$413 Million
Q1 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2023 Jan 29, 2024	BUY	$1.95 - $3.24 $544 - $903	279 New	279 $0

Others Institutions Holding ARMP

# of Institutions

Shares Held

1.42M

Call Options Held

200

Put Options Held

Bank Of America Corp Charlotte, NC

637K
Shares

$1.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

159K
Shares

$425,088
0.0% of portfolio
Bridgeway Capital Management, LLC Houston, TX

110K
Shares

$294,719
0.01% of portfolio
Edgewood Management LLC Greenwich, CT

100K
Shares

$267,000
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

99.9K
Shares

$266,700
0.0% of portfolio

View Full List

About Armata Pharmaceuticals, Inc.

Ticker ARMP
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,144,700
Market Cap $96.5M
Description
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...

More about ARMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tennessee Valley Asset Management Partners, based on Form 13F filings with the SEC.

News

Stay updated on Tennessee Valley Asset Management Partners with notifications on news.

Account